Abstract
Proteins with glycosylphosphatidylinositol (GPI) anchors exhibit a range of activities and some of these proteins exist in both a membrane-associated and a soluble form. CD48 is a 47-kd GPI-linked glycoprotein which is expressed on T and B lymphocytes, monocytes, and many lymphoid malignancies. The biological function of CD48 is unknown. We describe the detection of a soluble form of CD48 in plasma and serum. Its level was quantified by an immunoenzymometric assay (IEMA) specific for soluble CD48. While soluble CD48 was detected in the plasma of healthy individuals (median = 29 ng/ml; range, 15–48 ng/ml), elevated levels were detected in some patients with lymphoproliferative disease (median = 41 ng/ml; range, 9–213 ng/ml), arthritis (median = 42 ng/ml; range, 13–67 ng/ml), and acute EBV infection (174 ng/ml). Soluble CD48 was also detectable in tissue culture supernatants from the Raji lymphoid cell line. The mechanism of CD48 release from cells is unclear. The finding of significant levels of soluble CD48 in plasma and the development of a sensitive IEMA for its measurement will facilitate further studies on its normal function and its role in disease.
Article PDF
Similar content being viewed by others
REFERENCES
Low M, Saltiel A: Structural and functional roles of glycosylphosphatidylinositol in membranes. Science 239:268, 1988
Stefanova I, Horejsi V, Ansotegui I, Knapp W, Stockinger H: GPI-Anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016, 1991
Solomon KR, Rudd CE, Finberg RW: The association between GPI-anchored proteins and heterotrimeric G protein subunits in lymphocytes. Proc Natl Acad Sci USA 93:6053-6058, 1996
Kooyman D, Byrne G, McClennan S, Nielsen D, Tone M, Waldmann H, Coffman T, McCurry K, Platt J, Logan J: In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269:89, 1995
Gold P, Shuster J, Freedman S: Carcinoembryonic antigen (CEA) in clinical medicine. Cancer 42:1399, 1978
Fleit H, Kobasiuk C, Daly C, Furie R, Levy P, Webster R: A soluble form of FcγRIII is present in human serum and other body fluids and is elevated at sites of inflammation. Blood 79:2721, 1992
Bazil V, Strominger J: Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147:1567, 1991
Mizukami I, Faulkner N, Gyetko M, Sitrin R, Todd R: Enzymelinked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 86:203, 1995
Caras I, Davitz M, Rhee L, Weddell G, Martin D, Nussenzweig V: Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545, 1987
Bazil V: Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 16:135, 1995
Wang J, Tang R, Chiang J: Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 37:272, 1994
Henniker A, Bradstock K, Grimsley P, Atkinson M: A novel non-lineage antigen on human leucocytes: Characterization with two CD-48 monoclonal antibodies. Dis Mark 8:179, 1990
Vaughan H, Thompson C, Sparrow R, McKenzie I: HU LYM3—A human leukocyte antigen. Transplantation 36:446, 1983
Hadam M: Cluster report: CD48. Leucocyte Typing IV:661, 1989
Thorley-Lawson D, Ianelli C, Klaman L, Staunton D, Yokoyama S: Function of CD48 and its regulation by Epstein-Barr virus. Biochem Soc Trans 21:976, 1993
Kato K, Koyanagi M, Okada H, Takanashi T, Wah Wong Y, Williams A, Okumura K, Yagita H: CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 176:1241, 1992
Arulanandam A, Moingeon P, Concino M, Recny M, Kato K, Yagita H, Koyasu S, Reinherz E: A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: Divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 177:1439, 1993
Anton van der Merwe P, Barclay A, Mason D, Davies E, Morgan B, Tone M, Krishnam A, Ianelli C, Davis S: Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33:10149, 1994
Korinek V, Stefanova I, Angelisova P, Hilgert I, Horejsi V: The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker BLAST-1. Immunogenetics 33:108, 1991
Vaughan H, Henning M, Purcell D, McKenzie I, Sandrin M: The isolation of cDNA clones for CD48. Immunogenetics 33:113, 1991
Staunton D, Thorley-Lawson D: Molecular cloning of the lymphocyte activation marker BLAST-1. J Exp Med 169:1087, 1989
Fisher R, Thorley-Lawson D: Characterization of the Epstein-Barr virus-inducible gene encoding the human leucocyte adhesion and activation antigen BLAST-1 (CD48). Mol Cell Biol 11:1614, 1991
Calender A, Billaud M, Aubry J-P, Banchereau J, Vuillaume M, Lenoir G: Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci USA 84:8060, 1987
Thorley-Lawson D, Schooley R, Bhan A, Nadler L: Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 30:415, 1982
Yokoyama S, Staunton D, Fisher R, Amiot M, Fortin J, Thorley-Lawson D: Expression of the BLAST-1 activation/adhesion molecule and its identification as CD48. J Immunol 146:2192, 1991
Metz C, Brunner G, Choi-Muira N, Nguyen H, Gabrilove J, Caras I, Altszuler N, Rfikin D, Wilson E, Davitz M: Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 13:1741, 1994
Duke O, Panavi G, Janossy G, Poulter L: An immunohistochemical analysis of lymphocyte subpopulation and their microenvironment in the synovial membrane of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 49:22, 1982
Harlow E, Lane D: Antibodies. A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988
Metz C, Brunner G, Choi-Muira N, Nguyen H, Gabrilove J, Caras I, Altszuler N, Rifkin D, Wilson E, Davitz M: Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 13:1741, 1994
Rai KR, Sawitsky A, Cronkite EP, Chanana A, Levy RN, Pasternak BS: Clinical staging of chronic lymophcytic leukaemia. Blood 46:219-234, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, G.M., Biggs, J., Norris, B. et al. Detection of a Soluble Form of the Leukocyte Surface Antigen CD48 in Plasma and Its Elevation in Patients with Lymphoid Leukemias and Arthritis. J Clin Immunol 17, 502–509 (1997). https://doi.org/10.1023/A:1027327912204
Issue Date:
DOI: https://doi.org/10.1023/A:1027327912204